Stockholders' Equity (Tables)
|
9 Months Ended |
Sep. 30, 2016 |
|---|
| Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
|
| Schedule of Share-based Compensation, Activity |
The following table summarizes the stock-based compensation expense from stock option awards, restricted common stock awards, employee stock purchase programs and warrants granted by Fortress for the three and nine months ended September 30, 2016 and 2015: | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | ($ in thousands) | | 2016 | | 2015 | | 2016 | | 2015 | | | Employee awards | | $ | 1,937 | | $ | 3,296 | | $ | 5,490 | | $ | 6,284 | | | Executive awards of Fortress Companies' stock | | | - | | | 2,229 | | | - | | | 2,229 | | | Non-employee awards | | | 3 | | | 10 | | | 9 | | | 24 | | | Fortress Companies (1) | | | 963 | | | 2,966 | | | 3,293 | | | 3,359 | | | Total stock-based compensation expense | | $ | 2,903 | | $ | 8,501 | | $ | 8,792 | | $ | 11,896 | | | (1) | Consists of approximately $5,000 of Avenue's compensation expenses, approximately $0.8 million of Checkpoint's compensation expense, approximately $130,000 of JMC's compensation expenses and approximately $67,000 of Helocyte's compensation expenses on stock grants for the three months ended September 30, 2016, and approximately $23,000 of Avenue's compensation expenses, approximately $2.7 million of Checkpoint's compensation expense, approximately $458,000 of JMC's compensation expenses and approximately $160,000 of Helocyte's compensation expenses on stock grants for the nine months ended September 30, 2016. Consists of approximately $15,000 of Avenue's compensation expenses, approximately $2.1 million of Checkpoint's compensation expense and approximately $279,000 of JMC's compensation expenses on stock grants for the three months ended September 30, 2015, and approximately $38,000 of Avenue's compensation expenses, approximately $2.1 million of Checkpoint's compensation expense, approximately $279,000 of JMC's compensation expenses and approximately $147,000 of Mustang's compensation expenses on stock grants for the nine months ended September 30, 2015. |
|
| Schedule of Share-based Compensation, Stock Options, Activity |
The following table summarizes Fortress stock option activities excluding activity related to Fortress Companies: | | | Number of shares | | Weighted average
exercise price | | Total weighted
average intrinsic
value | | Weighted average
remaining
contractual life
(years) | | | Options vested and expected to vest at December 31, 2015 | | | 1,779,365 | | $ | 4.37 | | $ | 666,396 | | | 6.32 | | | Granted | | | - | | | - | | | - | | | - | | | Forfeited | | | (648,864) | | | 0.51 | | | - | | | - | | | Options vested and expected to vest at September 30, 2016 | | | 1,130,501 | | $ | 3.73 | | $ | 745,069 | | | 5.18 | | | Options vested and exercisable | | | 1,065,501 | | $ | 3.77 | | $ | 710,269 | | | 5.08 | |
|
| Nonvested Restricted Stock Shares Activity |
The following table summarizes Fortress’ restricted stock and restricted stock unit award activity, excluding activity related to Fortress Companies (which is discussed below): | | | Number of shares | | Weighted average
grant price | | | Unvested balance at December 31, 2015 | | | 8,757,935 | | $ | 2.47 | | | Restricted stock granted | | | 1,240,868 | | | 2.77 | | | Restricted stock cancelled | | | (33,333) | | | 2.69 | | | Restricted stock vested | | | (173,333) | | | 2.73 | | | Restricted stock units granted | | | 526,000 | | | 2.92 | | | Restricted stock units cancelled | | | (101,750) | | | 3.64 | | | Restricted stock units vested | | | (223,375) | | | 3.56 | | | Unvested balance at September 30, 2016 | | | 9,993,012 | | $ | 2.49 | |
|
| Schedule of Warrant Activities |
The following table summarizes Fortress warrant activities, excluding activities related to Fortress Companies: | | | Number of shares | | Weighted average
exercise price | | Total weighted
average intrinsic
value | | Weighted average
remaining
contractual life
(years) | | | Outstanding as of December 31, 2015 | | | 569,835 | | $ | 6.31 | | $ | 120,700 | | | 1.84 | | | Granted | | | 1,800,000 | | | 3.00 | | | - | | | 5.89 | | | Expired | | | (161,382) | | | 6.30 | | | - | | | - | | | Exercised (*) | | | (25,000) | | | 1.37 | | | 40,000 | | | - | | | Outstanding as of September 30, 2016 | | | 2,183,453 | | $ | 3.64 | | $ | 96,000 | | | 5.17 | | | Exercisable as of September 30, 2016 | | | 383,453 | | $ | 6.63 | | $ | 96,000 | | | 1.79 | | (*) - cashless
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The fair value of options granted in 2016 was estimated using the following assumptions: | | | For the nine
months ended
September 30, 2016 | | | Risk-free interest rate | | 1.14%- 1.82 | % | | Expected dividend yield | | - | | | Expected term in years | | 5.11-6.95 | | | Expected volatility | | 95.25% - 104.76 | % |
|